Recent studies, however, reported that the MYC-associated zinc finger protein (MAZ) and the interferon regulatory factor 5 (IRF5) are direct activators of Zfp217 transcription, contributing to, respectively, prostate cancer (PCa) and pancreatic cancer aggressiveness [21,22]. The gene discussed is MAZ; the disease is prostate carcinoma.